108 results
Page 4 of 6
8-K
EX-99.1
jh5dei
5 Nov 19
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:15am
8-K
EX-10.1
ejllfv2qqdefrhl 0s
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
424B5
sa7k58ws
2 Aug 19
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
8t0hrwn
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-99.1
m779rdtwstu o42if
2 May 19
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
3o4z5ay
13 Mar 19
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.1
eiart
7 Nov 18
Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
mxzr90
21 Sep 18
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
pphtmggjrhcdf
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
vonzyl2
19 Sep 18
Prospectus supplement for primary offering
4:27pm